Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.,Clinical and Molecular Hepatology

当前位置： X-MOL 学术 › Clin. Mol. Hepatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Clinical and Molecular Hepatology ( IF 8.9 ) Pub Date : 2024-04-19 , DOI: 10.3350/cmh.2024.0038
Pei-Chien Tsai , Chung-Feng Huang , Ming-Lun Yeh , Meng-Hsuan Hsieh , Hsing-Tao Kuo , Chao-Hung Hung , Kuo-Chih Tseng , Hsueh-Chou Lai , Cheng-Yuan Peng , Jing-Houng Wang , Jyh-Jou Chen , Pei-Lun Lee , Rong-Nan Chien , Chi-Chieh Yang , Gin-Ho Lo , Jia-Horng Kao , Chun-Jen Liu , Chen-Hua Liu , Sheng-Lei Yan , Chun-Yen Lin , Wei-Wen Su , Cheng-Hsin Chu , Chih-Jen Chen , Shui-Yi Tung , Chi‐Ming Tai , Chih-Wen Lin , Ching-Chu Lo , Pin-Nan Cheng , Yen-Cheng Chiu , Chia-Chi Wang , Jin-Shiung Cheng , Wei-Lun Tsai , Han-Chieh Lin , Yi-Hsiang Huang , Chi-Yi Chen , Jee-Fu Huang , Chia-Yen Dai , Wan-Long Wan-Long , Ming-Jong Bair , Ming-Lung Yu ,

Chronic hepatitis C (CHC) patients who fail antiviral therapy have a high risk of developing hepatocellular carcinoma (HCC). We investigated the effects of metformin and statins, commonly used to treat diabetes mellitus (DM) and hyperlipidemia (HLP), on HCC risk in CHC patients who failed antiviral therapy.

中文翻译：

二甲双胍和他汀类药物可降低抗病毒治疗失败的慢性丙型肝炎患者患肝细胞癌的风险。

抗病毒治疗失败的慢性丙型肝炎（CHC）患者患肝细胞癌（HCC）的风险很高。我们研究了常用于治疗糖尿病 (DM) 和高脂血症 (HLP) 的二甲双胍和他汀类药物对抗病毒治疗失败的 CHC 患者的 HCC 风险的影响。

更新日期：2024-04-19

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文

全部期刊列表>>